{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:15Z","timestamp":1790787795565,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.hrthm.2020.02.033","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T20:28:36Z","timestamp":1583526516000},"page":"1151-1158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Lucy Y.","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.02.033_bib1","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.02.033_bib2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1540-8167.2006.00595.x","article-title":"Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years","volume":"17","author":"Ganzeboom","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/pace.13559","article-title":"Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals","volume":"42","author":"Ng","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/eurheartj\/ehi647","article-title":"A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals","volume":"27","author":"Brignole","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.02.033_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0735-1097(92)90498-C","article-title":"Use of intravenous esmolol to predict efficacy of oral \u03b2-adrenergic blocker therapy in patients with neurocardiogenic syncope","volume":"19","author":"Sra","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCULATIONAHA.105.535161","article-title":"Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope","volume":"113","author":"Sheldon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.02.033_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2016.04.030","article-title":"Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial","volume":"68","author":"Sheldon","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.79.1.45","article-title":"Midodrine: a role in the management of neurocardiogenic syncope","volume":"79","author":"Ward","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2020.02.033_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/europace\/eur200","article-title":"Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial)","volume":"13","author":"Romme","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.02.033_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.10293","article-title":"Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study","volume":"52","author":"Kaufmann","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jpeds.2006.07.031","article-title":"The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope","volume":"149","author":"Qingyou","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.hrthm.2020.02.033_bib12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1540-8167.2001.00935.x","article-title":"Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study","volume":"12","author":"Perez-Lugones","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1540-8159.1993.tb01608.x","article-title":"Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope","volume":"16","author":"Grubb","year":"1993","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0735-1097(98)00694-9","article-title":"Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study","volume":"33","author":"Di Girolamo","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.jacc.2017.03.003","article-title":"2017 ACC\/AHA\/HRS Guideline for the Evaluation and Management of Patients With Syncope: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"70","author":"Shen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC Guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.02.033_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003878","article-title":"Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications","volume":"3","author":"Tellioglu","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.hrthm.2020.02.033_bib18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","article-title":"Paradoxical effect of sibutramine on autonomic cardiovascular regulation","volume":"106","author":"Birkenfeld","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.02.033_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jacc.2006.04.073","article-title":"Norepinephrine transporter inhibition prevents tilt-induced pre-syncope","volume":"48","author":"Schroeder","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/hc0302.102597","article-title":"Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance","volume":"105","author":"Schroeder","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.02.033_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/europace\/euz250","article-title":"A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI","volume":"21","author":"Sheldon","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.02.033_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2020.02.033_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2020.02.033_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2020.02.033_bib25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.hrthm.2020.02.033_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.78.1.41","article-title":"In\u00a0vivo measurement of neuronal uptake of norepinephrine in the human heart","volume":"78","author":"Goldstein","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.02.033_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jacep.2016.10.012","article-title":"High remission rates in vasovagal syncope: systematic review and meta-analysis of observational and randomized studies","volume":"3","author":"Pournazari","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jce.12111","article-title":"Norepinephrine transport inhibition for treatment of vasovagal syncope","volume":"24","author":"Sheldon","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.113.000395","article-title":"Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome","volume":"2","author":"Green","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2020.02.033_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCEP.113.001103","article-title":"Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3)","volume":"7","author":"Brignole","year":"2014","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib31","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jacc.2017.08.026","article-title":"Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study","volume":"70","author":"Baron-Esquivias","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2020.02.033_bib33","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0735-1097(93)90767-U","article-title":"A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt","volume":"22","author":"Morillo","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib34","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/0002-9149(90)91321-V","article-title":"Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study","volume":"65","author":"Raviele","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.02.033_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0735-1097(97)00255-6","article-title":"Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects","volume":"30","author":"Lewis","year":"1997","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120301879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120301879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:17:33Z","timestamp":1778818653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120301879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1547527120301879"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.02.033","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}